• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Naming Guidelines Issued for One of the Top Overseas Product Groups

Naming Guidelines Issued for One of the Top Overseas Product Groups

Tuesday, 28 September 2021 / Published in Medical Device, News, NMPA Registration in China

Naming Guidelines Issued for One of the Top Overseas Product Groups

On August 25, 2021, the NMPA (National Medical Products Administration) published (No.62-2021) the Guidelines for the Nomenclature of Neurological and Cardiovascular Surgical Instruments, and the Guidelines for Medical Diagnostic and Monitoring Instruments in China.

Highlights

  • Both guidelines were formulated in accordance with the current Guidelines for the Nomenclature for Common Names of Medical Devices.
  • The Chinese names of medical devices are formed in the combination of a maximum of three characteristics words and one core word.
  • Core words are general expressions for medical instruments that have the same or similar technical principles, structural composition or intended purpose. For example: “Hemostatic Clamp”, “Catheter”, “Electrocardiogram machine”, etc.
  • Characteristics words are descriptions of specific attributes such as the use of medical device parts, structural features, technical features or material composition. For example: “Microscopic”, “Heart”, “Single-use”, etc.
  • Naming example of a medical diagnostic and monitoring device: Fixed (characteristics word) + Curve (characteristics word) + Diagnostic Catheter (core word) = 固定弯标测导管 (Fixed curve diagnostic catheter)
  • Some characteristics words without appearing in the product names can still be understood for the same meaning by default. For instance, pulse oximetry sensors are intended to be either “single-use” or “reusable”, while “single-use pulse oximetry sensors” is clear and commonly used for this indication, “pulse oximetry sensors” will be understood as a “reusable” product even without the word showing in the product name.

There has been a continuous focus on the supply of high-end, high-cost medical devices in China, and Neurological and Cardiovascular Surgical Instruments have been one of the top five class II and III product groups of foreign origin to be registered in 2019 and 2020. We expect further announcements will be made in future to strengthen the regulatory framework of product groups focused in China.

By Colleen Xu and Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Medical Diagnostic and Monitoring Instruments, Naming Guidelines, Neurological and Cardiovascular Surgical Instruments

What you can read next

CMDE Publishes Case Studies on IVDs and SiMDs in August 2021
China UDI requirements
China UDI requirements for third batch of medical devices – Draft issued
Acceptance and Examination of Chemical APIs
Procedures for initiating verification and testing of drug registration (Trial) in 2022

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.